Literature DB >> 29802354

Cerebral small vessel disease: from a focal to a global perspective.

Annemieke Ter Telgte1, Esther M C van Leijsen1, Kim Wiegertjes1, Catharina J M Klijn1, Anil M Tuladhar1, Frank-Erik de Leeuw2.   

Abstract

Cerebral small vessel disease (SVD) is commonly observed on neuroimaging among elderly individuals and is recognized as a major vascular contributor to dementia, cognitive decline, gait impairment, mood disturbance and stroke. However, clinical symptoms are often highly inconsistent in nature and severity among patients with similar degrees of SVD on brain imaging. Here, we provide a new framework based on new advances in structural and functional neuroimaging that aims to explain the remarkable clinical variation in SVD. First, we discuss the heterogeneous pathology present in SVD lesions despite an identical appearance on imaging and the perilesional and remote effects of these lesions. We review effects of SVD on structural and functional connectivity in the brain, and we discuss how network disruption by SVD can lead to clinical deficits. We address reserve and compensatory mechanisms in SVD and discuss the part played by other age-related pathologies. Finally, we conclude that SVD should be considered a global rather than a focal disease, as the classically recognized focal lesions affect remote brain structures and structural and functional network connections. The large variability in clinical symptoms among patients with SVD can probably be understood by taking into account the heterogeneity of SVD lesions, the effects of SVD beyond the focal lesions, the contribution of neurodegenerative pathologies other than SVD, and the interaction with reserve mechanisms and compensatory mechanisms.

Entities:  

Mesh:

Year:  2018        PMID: 29802354     DOI: 10.1038/s41582-018-0014-y

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  97 in total

1.  Venous disruption affects white matter integrity through increased interstitial fluid in cerebral small vessel disease.

Authors:  Ruiting Zhang; Peiyu Huang; Yeerfan Jiaerken; Shuyue Wang; Hui Hong; Xiao Luo; Xiaopei Xu; Xinfeng Yu; Kaicheng Li; Qingze Zeng; Xiao Wu; Min Lou; Minming Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2020-02-16       Impact factor: 6.200

2.  The vessel density of the superficial retinal capillary plexus as a new biomarker in cerebral small vessel disease: an optical coherence tomography angiography study.

Authors:  Xiaojing Wang; Qiang Wei; Xingqi Wu; Shanshan Cao; Chen Chen; Jun Zhang; Yibing Yan; Zhi Geng; Yanghua Tian; Kai Wang
Journal:  Neurol Sci       Date:  2021-01-11       Impact factor: 3.307

3.  Linking cortical atrophy to white matter hyperintensities of presumed vascular origin.

Authors:  Carola Mayer; Benedikt M Frey; Eckhard Schlemm; Marvin Petersen; Kristin Engelke; Uta Hanning; Annika Jagodzinski; Katrin Borof; Jens Fiehler; Christian Gerloff; Götz Thomalla; Bastian Cheng
Journal:  J Cereb Blood Flow Metab       Date:  2020-12-01       Impact factor: 6.200

4.  Genome-wide association study of cerebral small vessel disease reveals established and novel loci.

Authors:  Jaeyoon Chung; Sandro Marini; Joanna Pera; Bo Norrving; Jordi Jimenez-Conde; Jaume Roquer; Israel Fernandez-Cadenas; David L Tirschwell; Magdy Selim; Devin L Brown; Scott L Silliman; Bradford B Worrall; James F Meschia; Stacie Demel; Steven M Greenberg; Agnieszka Slowik; Arne Lindgren; Reinhold Schmidt; Matthew Traylor; Muralidharan Sargurupremraj; Steffen Tiedt; Rainer Malik; Stéphanie Debette; Martin Dichgans; Carl D Langefeld; Daniel Woo; Jonathan Rosand; Christopher D Anderson
Journal:  Brain       Date:  2019-10-01       Impact factor: 13.501

Review 5.  Vascular Cognitive Impairment and Dementia: JACC Scientific Expert Panel.

Authors:  Costantino Iadecola; Marco Duering; Vladimir Hachinski; Anne Joutel; Sarah T Pendlebury; Julie A Schneider; Martin Dichgans
Journal:  J Am Coll Cardiol       Date:  2019-07-02       Impact factor: 24.094

6.  Hypertension, seizures, and epilepsy: a review on pathophysiology and management.

Authors:  Sara Gasparini; Edoardo Ferlazzo; Chiara Sueri; Vittoria Cianci; Michele Ascoli; Salvatore M Cavalli; Ettore Beghi; Vincenzo Belcastro; Amedeo Bianchi; Paolo Benna; Roberto Cantello; Domenico Consoli; Fabrizio A De Falco; Giancarlo Di Gennaro; Antonio Gambardella; Gian Luigi Gigli; Alfonso Iudice; Angelo Labate; Roberto Michelucci; Maurizio Paciaroni; Pasquale Palumbo; Alberto Primavera; Ferdinando Sartucci; Pasquale Striano; Flavio Villani; Emilio Russo; Giovambattista De Sarro; Umberto Aguglia
Journal:  Neurol Sci       Date:  2019-05-04       Impact factor: 3.307

7.  Effects of ginkgo diterpene lactone on brain inflammation and oxidative stress in rats with cognitive impairment of cerebral small vessel disease.

Authors:  Shan Jiang; Xianjun Ma; Yinyi Chen; Baodong Gu; Na Sun; Hui Xiao
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

8.  Diffuse white matter loss in a transgenic rat model of cerebral amyloid angiopathy.

Authors:  Hedok Lee; Feng Xu; Xiaodan Liu; Sunil Koundal; Xiaoyue Zhu; Judianne Davis; David Yanez; Joseph Schrader; Aleksandra Stanisavljevic; Douglas L Rothman; Joanna Wardlaw; William E Van Nostrand; Helene Benveniste
Journal:  J Cereb Blood Flow Metab       Date:  2020-08-13       Impact factor: 6.200

Review 9.  Epidemiology and treatment of multiple sclerosis in elderly populations.

Authors:  Caila B Vaughn; Dejan Jakimovski; Katelyn S Kavak; Murali Ramanathan; Ralph H B Benedict; Robert Zivadinov; Bianca Weinstock-Guttman
Journal:  Nat Rev Neurol       Date:  2019-06       Impact factor: 42.937

10.  Cognitive consequences of regression of cerebral small vessel disease.

Authors:  Esther Mc van Leijsen; Mayra I Bergkamp; Ingeborg Wm van Uden; Sjacky Cooijmans; Mohsen Ghafoorian; Helena M van der Holst; David G Norris; Roy Pc Kessels; Bram Platel; Anil M Tuladhar; Frank-Erik de Leeuw
Journal:  Eur Stroke J       Date:  2018-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.